The authors report that neutralization of CXCL12 with an antibody promotes tumor extension to nearby tissues, accelerates angiogenesis and neovascularization, increases VEGF expression, microvascular permeability and increases CXCR7 expression [199]. The gene discussed is ACKR3; the disease is neoplasm.